Korean Market
EXCH
Enzychem Lifesciences
★

Court Dismisses Temporary Shareholder Status Application, Resolves Management Dispute Risk

 
EXCH
Enzychem Lifesciences
★

Withdrawal of Shareholder Register Inspection Injunction Eliminates Near-Term Litigation Risk

 
OWNR
Enzychem Lifesciences
★

Enzychem Lifesciences Minority Shareholder Proxy Solicitation Correction, No Financial Impact

 
OWNR
Enzychem Lifesciences
★

Enzychem Lifesciences Minority Shareholder Proxy Amendment Corrects Typo, No Financial Impact

 
OWNR
Enzychem Lifesciences
★

Minor Correction in Proxy Solicitation by Enzychem Lifesciences Minority Shareholder, No Change to Agenda

 
EXCH
Enzychem Lifesciences
★

Individual Shareholder Nam Expands Injunction Scope Against Enzychem Lifesciences Temporary Meeting; Management Dispute Intensifies

 
EXCH
Enzychem Lifesciences
★

Enzychem Lifesciences Corrects Shareholder Registry Inspection Application, Changes Reference Date to June 29 2026

 
EXCH
Enzychem Lifesciences
★

Individual Shareholder Files Provisional Disposition Against Enzychem Lifesciences for Accounting Book Inspection, Raising Governance Concerns

 
EXCH
Enzychem Lifesciences
★

Shareholder Files Request to Inspect Shareholder Registry, Escalating Management Dispute at Enzychem Lifesciences

 
EXCH
Enzychem Lifesciences
★

Individual Shareholder Nam Files Injunction to Halt Enzychem Lifesciences EGM as Governance Dispute Intensifies

 
OWNR
Enzychem Lifesciences
★

Enzychem Lifesciences Amends Proxy Solicitation to Include Stock Trading Resumption Purpose

 
OWNR
Enzychem Lifesciences
★

Minority Shareholder of Enzychem Lifesciences Solicits Proxies to Oppose Executive Officer System and Real Estate Business Addition at EGM

 
OWNR
Enzychem Lifesciences
★

Enzychem Lifesciences 2026 EGM Proxy Solicitation, Articles Amendment Introduces Executive Officer System and Abolishes Golden Parachute

 
OTHR
Enzychem Lifesciences
★

Enzychem Lifesciences Calls 2026 EGM: Charter Amendments for New Business and Governance Reform

 
OWNR
Enzychem Lifesciences
★

Bridget Life Sciences Reports 0.01% Decrease in Enzychem Lifesciences Stake and Changes in Collateral Loans – Minimal Impact on Shareholder Value